Moxie Dwight

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2024-03-19	2024-03-18	Revance Therapeutics Inc (RVNC)	S Sale	8,125 -5.6% 5.04 USD 40,971	8,125 -5.6%	5.04	USD 40,971
2023-09-07	2023-09-06	Revance Therapeutics Inc (RVNC)	PS Planned sale	11,000 -20.0% 17.06 USD 187,704	11,000 -20.0%	17.06	USD 187,704
2023-09-07	2023-09-05	Revance Therapeutics Inc (RVNC)	PS Planned sale	23,853 -30.2% 17.81 USD 424,920	23,853 -30.2%	17.81	USD 424,920
2023-05-16	2023-05-15	Revance Therapeutics Inc (RVNC)	S Sale	21,401 -23.6% 34.55 USD 739,338	21,401 -23.6%	34.55	USD 739,338
2023-03-09	2023-03-09	Revance Therapeutics Inc (RVNC)	S Sale	18,496 -25.0% 31.59 USD 584,220	18,496 -25.0%	31.59	USD 584,220
2022-09-16	2022-09-14	Revance Therapeutics Inc (RVNC)	PS Planned sale	11,000 -25.8% 27.07 USD 297,798	11,000 -25.8%	27.07	USD 297,798
2021-09-28	2021-09-27	Revance Therapeutics Inc (RVNC)	PS Planned sale	1,675 -3.4% 30.00 USD 50,250	1,675 -3.4%	30.00	USD 50,250